GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $18.33 $26.57 Thursday, 18th Apr 2024 PHVS stock ended at $18.42. This is 13.11% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 15.63% from a day low at $18.33 to a day high of $21.19.
90 days $18.33 $33.00
52 weeks $7.93 $33.00

Historical Pharvaris B.V. prices

Date Open High Low Close Volume
2024-04-18 $21.19 $21.19 $18.33 $18.42 69 227
2024-04-17 $21.36 $21.58 $20.73 $21.20 327 194
2024-04-16 $20.26 $21.42 $19.94 $21.00 64 212
2024-04-15 $21.75 $21.75 $19.86 $20.15 167 178
2024-04-12 $22.45 $23.23 $21.71 $21.90 10 915
2024-04-11 $23.94 $24.08 $21.92 $22.31 78 107
2024-04-10 $22.80 $22.99 $21.49 $22.27 155 333
2024-04-09 $22.75 $23.20 $22.35 $23.14 11 788
2024-04-08 $22.72 $23.29 $22.06 $22.74 64 228
2024-04-05 $22.00 $22.98 $22.00 $22.56 53 234
2024-04-04 $21.60 $22.98 $21.21 $22.43 35 904
2024-04-03 $21.57 $22.44 $21.57 $22.29 31 882
2024-04-02 $21.58 $22.15 $20.86 $22.15 79 706
2024-04-01 $23.24 $25.19 $21.61 $21.64 26 435
2024-03-28 $21.16 $23.61 $21.16 $23.11 8 740
2024-03-27 $24.07 $24.07 $22.76 $23.50 21 291
2024-03-26 $21.11 $23.69 $21.05 $23.69 40 572
2024-03-25 $24.36 $24.68 $20.50 $21.26 77 098
2024-03-22 $25.05 $25.55 $24.35 $24.35 27 576
2024-03-21 $25.00 $25.71 $23.75 $25.00 42 190
2024-03-20 $26.21 $26.49 $24.17 $24.93 83 127
2024-03-19 $24.85 $26.57 $24.85 $25.99 46 307
2024-03-18 $23.28 $26.08 $22.82 $24.83 73 395
2024-03-15 $23.43 $23.88 $22.93 $23.35 118 279
2024-03-14 $23.50 $23.68 $23.12 $23.68 57 845
Click to get the best stock tips daily for free!

About Pharvaris B.V.

Pharvaris B.V. Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical ... PHVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT